Pain
Feature
Drug crisis continues to evolve beyond opioids
Primary care physicians “are well intentioned but underprepared and may miss some of the drug misuse risks affecting their patients,” says the...
News from the FDA/CDC
FDA approves Reyvow for acute migraine treatment
The approval of lasmiditan (Reyvow) is based on a pair of randomized, double-blind, placebo-controlled trials that included more than 3,000...
Conference Coverage
Consider centralized pain in patients with rheumatic disease
LAS VEGAS – Every patient with chronic pain should complete a fibromyalgia survey, Dr. Daniel J. Clauw says.
Pearl of the Month
Does this patient have bacterial conjunctivitis?
After ruling out serious eye disease, clinicians need to determine which cases of suspected conjunctivitis are most likely to be bacterial.
From the Journals
Sensory feedback may smooth walking with a prosthetic leg
Neural stimulation was associated with faster walking speeds, increased confidence, greater metabolic efficiency, and reduced phantom limb pain....
Latest News
CDC, SAMHSA commit $1.8 billion to combat opioid crisis
Some of the funds will be used to help improve overdose monitoring.
From the Journals
Cannabidiol may interact with rheumatologic drugs
CBD is known to inhibit the cytochrome P450 enzymes that metabolize corticosteroids and other medications.
Latest News
USPSTF draft guidance calls for drug use screening
They found “adequate evidence” that screening tools can detect illicit drug use.
Conference Coverage
Treatment of episodic cluster headache deviates from recommendations
PHILADELPHIA – Among patients with episodic cluster headache, use of acute medications is high, but use of...
News from the FDA/CDC
CDC finds that too little naloxone is dispensed
Despite increases in the number of naloxone prescriptions dispensed, many patients at risk for overdose are not offered the potentially life-...
From the Journals
COPD adds complexity to shared decision making for LDCT lung cancer screening
Current guidelines stress the importance of shared decision making, with discussion of the risks and benefits of screening.